-
2022-502425-18-00
5
2022-04-19
Adenocarcinoma of the prostate
-
2023-509138-21-00
5
2021-08-26
Pulmonary Arterial Hypertension (PAH)
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2022-500966-82-00
5
2020-03-11
Resectable locally advanced squamous cell carcinoma (SCC) of the esoph
-
2025-522301-37-00
4
2026-06-24
Nonsegmental vitiligo
-
2023-510559-41-00
4
2026-06-15
Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
-
2024-517749-15-00
11
2026-06-12
Postoperative critical care
-
2024-518018-22-00
5
2026-06-11
staphylococcal endocarditis
-
2025-524078-40-00
5
2026-06-10
Chronic Spontaneous Urticaria
-
2023-505046-26-00
5
2026-05-07
Colon carcinoma
-
2025-521889-95-00
6
2026-05-04
Crohn's Disease
-
2025-523690-41-00
5
2026-05-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2023-509891-40-00
5
2026-04-28
Pulmonary arterial hypertension
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2023-507801-32-00
6
2026-04-22
Isolated Subsegmental Pulmonary Embolism
-
2024-520014-22-00
5
2026-04-22
Locally advanced/metastatic urothelial carcinoma
-
2024-520205-39-00
5
2026-04-21
Traumatic brain injury
-
2024-517674-23-00
5
2026-04-09
Subjects undergoing elective endovascular coiling-only repair of unrup
-
2025-523263-37-00
10
2026-04-08
Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal
-
2024-516639-28-00
5
2026-03-27
norepinephrine-refractory vasoplegic shock
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia
-
2024-516643-64-00
5
2026-03-13
Aortic bioprothesis implanted patient for valvular heart disease
-
2024-519444-33-00
5
2026-03-12
HER2-expressing endometrial cancer (IHC 3+/2+)
-
2023-506291-28-00
5
2026-03-02
Patient with locally advanced/metastatic, MSI-H/dMMR gastric cancer